IGF-1 LR3 is carefully administered and monitored to maximize benefits while ensuring your overall health and safety
Avoid drinking 30 minutes before/after meals to prevent fullness
Differences across dose subgroups The recommended doses of tirzepatide are 2.5 mg, 5.0 mg, 7.5 mg, 10.0 mg, 12.5 mg, or 15.0 mg administered via subcutaneous injection weekly
It can cause: cartilage breakdown misshapen bones chronic pain inflammation stiffness loss of mobility Obesity is one cause of osteoarthritis due to the strain that added weight put on joints, especially the knees, hips, and the spine
Product Overview This precise 1:1 co-lyophilized blend combines a synthetic gastric-derived pentadecapeptide (BPC-157) with an actin-sequestering protein derivative (TB-500 / Thymosin $\beta$4)
Stable in gastric juice and resistant to acidic degradation